UBS AM’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $3.72M | Buy |
|
|||||
|
2024
Q1 | $3.59M | Buy |
|
|||||
|
2023
Q4 | $3.59M | Buy |
|
|||||
|
2023
Q3 | $1.55M | Buy |
|
|||||
|
2023
Q2 | $1.49M | Hold |
|
|||||
|
2023
Q1 | $1.49M | Buy |
|
|||||
|
2022
Q4 | $1.62M | Buy |
|
|||||
|
2022
Q3 | $1.41M | Sell |
|
|||||
|
2022
Q2 | $1.64M | Buy |
|
|||||
|
2022
Q1 | $1.18M | Hold |
|
|||||
|
2021
Q4 | $1.1M | Buy |
|
|||||
|
2021
Q3 | $982K | Buy |
|